Insulet News - August 2026
🟢 Insulet is trading 11.08% up in after-hours trading; immediate trigger remains unclear
Insulet is trading 11.08% up at $164.43 after closing at $148.03 on August 18, 2026; the immediate after-hours trigger remains unclear. - Available August 18...
🟢 Insulet is trading 15.13% up in after-hours trading
Insulet is trading 15.13% up at $167.01 after closing at $145.06 on August 12, 2026; no clear company-specific catalyst explaining the after-hours surge was...
🟢 Insulet is trading 9.51% up in after-hours trading
Insulet is trading 9.51% up at $158.85 in after-hours trading, but the catalyst remains unclear. - Shares closed at $145.06 on August 12, 2026. - No new...
Insulet Beats on Every Q2 Metric Then Cuts the Outlook — Can the Type 2 Diabetes Bet Still Justify the Stock Price?
Shares of Insulet Corporation cratered 10.1% to $149.98 after the insulin-pump maker delivered a paradox: a strong quarter followed by a weaker road ahead....
🔴 Insulet is trading 23% down today as 2026 sales guidance cut offsets Q2 beat
Insulet is trading 23% down at $131.65 after its second-quarter earnings release showed strong revenue and EPS beats but a cut to full-year 2026 sales...
🔴 Insulet is trading 10.1% down today on lowered FY26 sales outlook and Omnipod guidance
Insulet is trading 10.1% down at $149.98 after the company lowered its long-term sales outlook despite beating Q2 earnings expectations. • The company cut its...
Insulet's second quarter revenue grew 23.5% to beat estimates, but the company lowered its full-year 2026 sales forecast.
Insulet reported second quarter revenue of $801.7 million, up 23.5% year-over-year, and adjusted EPS of $1.66. These results surpassed analyst expectations for...
Insulet Corporation Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Analysts expect Insulet to report Q2 2026 revenue of $787.4 million and earnings of $1.44 per share, with the stock currently trading at $165.35 against an...